Skip to main content

Medicinal Products: Borderline Cases

Volume 604: debated on Friday 16 July 1999

The text on this page has been created from Hansard archive content, it may contain typographical errors.

asked Her Majesty's Government:What is the outcome of their consideration of the public response to the Medicines Control Agency's proposals for classifying borderline products, as published in its consultation letter MLX 249. [HL3715]

We have carefully considered all the areas of concern raised by respondents in what has been a very active consultation process. We will be announcing our detailed response on specific issues and we will be responding positively to all the main concerns raised. There has never been any intention to, and there is no effect in these proposals that would, change the definition of a medicinal product. The Government's intention is to ensure that the legal obligation to protect public health is safeguarded while maintaining public access to a range of safe dietary supplements and natural products.